We are live on ! Find out more
SP

Steelhead Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 0.01%
This Fund
S&P 500
This Quarter Est. Return
0%
1 Year Est. Return
+0.01%
3 Year Est. Return
+0.04%
5 Year Est. Return
+0.04%
10 Year Est. Return
+4.69%
AUM
$1.37B
AUM Growth
+$22.1M
Cap. Flow
-$1.15B
Cap. Flow %
-83.46%
Top 10 Hldgs %
42.25%
Holding
42
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$721K

Sector Composition

Rank Sector Weight
1 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNY icon
1
Alnylam Pharmaceuticals
ALNY
$36.3B
-3,600
Closed -$721K

Similar funds

Steelhead Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Steelhead Partners held 42 positions worth $1.37B, up 1.6% from $1.35B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Steelhead Partners withdrew a net $1.15B in Q4 2022, closing 1 position. Its most notable exit was Alnylam Pharmaceuticals, an estimated $721K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 0% of assets, down from 0.05% a quarter earlier.

  • Steelhead Partners fully exited Alnylam Pharmaceuticals in Q4 2022, selling an estimated $721K.
  • Steelhead Partners's ten largest holdings make up 42% of its $1.37B portfolio in Q4 2022.
  • Steelhead Partners opened 0 new positions and closed 1 in Q4 2022.
  • Steelhead Partners's portfolio value rose 1.6% quarter-over-quarter to $1.37B.

Based on Steelhead Partners's 13F filing for Q4 2022, filed 14 Feb 2023.